Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Tarning

Showing results (131-140 of 248) with videos related to

Pageof 25
Sort By:
Malaria Journal|August 24, 2012
Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in UgandaJoel Tarning, Frank Kloprogge, Patrice Piola, et al.
Antimicrobial Agents and Chemotherapy|August 29, 2012
Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancyJoel Tarning, Palang Chotsiri, Vincent Jullien, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2009
Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malariaJoel Tarning, Rose McGready, Niklas Lindegardh, et al.
Nature Communications|November 27, 2014
Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysisLucy C Okell, Matthew Cairns, Jamie T Griffin, et al.
Malaria Journal|June 5, 2024
Bioequivalence of a new coated 15 mg primaquine formulation for malaria eliminationJulie Nguyen Ngoc Pouplin, Thoopmanee Kaendiao, Bilal Ahmad Rahimi, et al.
British Journal of Clinical Pharmacology|November 20, 2025
Safety, tolerability and pharmacokinetics of DNDI-6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participantsJean-Yves Gillon, Sophie Delhomme, Delphine Launay, et al.
Antimicrobial Agents and Chemotherapy|June 29, 2011
Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malariaMarcus J Rijken, Rose McGready, Vincent Jullien, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2011
Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malariaMarcus J Rijken, Rose McGready, Aung Phae Phyo, et al.
Emerging Infectious Diseases|March 22, 2017
Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, VietnamBui Quang Phuc, Charlotte Rasmussen, Tran Thanh Duong, et al.
Antimicrobial Agents and Chemotherapy|May 14, 2024
Safety, pharmacokinetics, and potential neurological interactions of ivermectin, tafenoquine, and chloroquine in Rhesus macaquesPattaraporn Vanachayangkul, Chanikarn Kodchakorn, Winita Ta-Aksorn, et al.
Pageof 25

Showing results (131-140 of 248) with videos related to

Sort By:
Pageof 25
Malaria Journal|August 24, 2012
Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in UgandaJoel Tarning, Frank Kloprogge, Patrice Piola, et al.
Antimicrobial Agents and Chemotherapy|August 29, 2012
Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancyJoel Tarning, Palang Chotsiri, Vincent Jullien, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2009
Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malariaJoel Tarning, Rose McGready, Niklas Lindegardh, et al.
Nature Communications|November 27, 2014
Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysisLucy C Okell, Matthew Cairns, Jamie T Griffin, et al.
Malaria Journal|June 5, 2024
Bioequivalence of a new coated 15 mg primaquine formulation for malaria eliminationJulie Nguyen Ngoc Pouplin, Thoopmanee Kaendiao, Bilal Ahmad Rahimi, et al.
British Journal of Clinical Pharmacology|November 20, 2025
Safety, tolerability and pharmacokinetics of DNDI-6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participantsJean-Yves Gillon, Sophie Delhomme, Delphine Launay, et al.
Antimicrobial Agents and Chemotherapy|June 29, 2011
Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malariaMarcus J Rijken, Rose McGready, Vincent Jullien, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2011
Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malariaMarcus J Rijken, Rose McGready, Aung Phae Phyo, et al.
Emerging Infectious Diseases|March 22, 2017
Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, VietnamBui Quang Phuc, Charlotte Rasmussen, Tran Thanh Duong, et al.
Antimicrobial Agents and Chemotherapy|May 14, 2024
Safety, pharmacokinetics, and potential neurological interactions of ivermectin, tafenoquine, and chloroquine in Rhesus macaquesPattaraporn Vanachayangkul, Chanikarn Kodchakorn, Winita Ta-Aksorn, et al.
Pageof 25